Stocks
J&J Keeps Dividend Streak Alive with 64th Consecutive Raise
Johnson & Johnson has increased its dividend for the 64th consecutive year, paying $1.34 per share quarterly. This marks a 3.1% raise and reflects the company's commitment to returning capital to shareholders.
The pharmaceutical giant maintains a strong financial position with a payout ratio near 48%, supported by robust operating cash flow of $24.53 billion in 2025 against a $12.38 billion dividend payout.
Despite competitive pressures on its drug STELARA, JNJ's innovative medicines continue to grow, with sales reaching $25.3 billion in Q2 2026 and adjusted EPS guidance raised for 2026.